These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1741912)
41. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents. Focht J; Klietmann W; Nösner K Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166 [TBL] [Abstract][Full Text] [Related]
42. Mutation rates to 4-quinolone resistance. Smith JT Arzneimittelforschung; 1990 Jan; 40(1):65-8. PubMed ID: 2111135 [TBL] [Abstract][Full Text] [Related]
43. Tissues and exudates contain sufficient thymidine for growth of anaerobic bacteria in the presence of inhibitory levels of trimethoprim-sulfamethoxazole. Indiveri MC; Hirsh DC Vet Microbiol; 1992 Jun; 31(2-3):235-42. PubMed ID: 1626372 [TBL] [Abstract][Full Text] [Related]
44. Comparison of bedside- and laboratory-inoculated Bactec high- and low-volume resin bottles for the recovery of microorganisms causing peritonitis in CAPD patients. Blondeau JM; Pylypchuk GB; Kappel JE; Pilkey B; Lawler C Diagn Microbiol Infect Dis; 1998 May; 31(1):281-7. PubMed ID: 9597388 [TBL] [Abstract][Full Text] [Related]
45. Comparative study of a non-radiometric BACTEC system and a conventional blood culture system in a clinical microbiology laboratory. Yew OF; Cheong YM; Zaidatul AR; Thanaletchimy N Malays J Pathol; 1995 Jun; 17(1):11-5. PubMed ID: 8906999 [TBL] [Abstract][Full Text] [Related]
46. Conditions required for the antibacterial activity of zidovudine. Lewin CS; Amyes SG Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):737-41. PubMed ID: 2506045 [TBL] [Abstract][Full Text] [Related]
47. The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Osato MS; Jensen HG; Trousdale MD; Bosso JA; Borrmann LR; Frank J; Akers P Am J Ophthalmol; 1989 Oct; 108(4):380-6. PubMed ID: 2519514 [TBL] [Abstract][Full Text] [Related]
48. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections. Tiengrim S; Phiboonbanakit D; Thunyaharn S; Tantisiriwat W; Santiwatanakul S; Susaengrat W; Srisurat N; Malithong A; Srisangchan P; Thamlikitkul V J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S6-17. PubMed ID: 22574524 [TBL] [Abstract][Full Text] [Related]
49. [Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants]. Cullmann W; Dechène M; Stieglitz M Immun Infekt; 1988 Aug; 16(4):152-8. PubMed ID: 3141267 [TBL] [Abstract][Full Text] [Related]
51. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Fox BC; Sollinger HW; Belzer FO; Maki DG Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307 [TBL] [Abstract][Full Text] [Related]
52. Ofloxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbation of chronic bronchitis. Study of Ofloxacin in Lower Respiratory Tract Infections Research Group. Pérez-Gonzalvo ME; Mosquera-Pestaña JA; Ramos D; Apilánez J; Borja J; Arnau C; García-Barbal J; Marín-Pardo J Clin Ther; 1996; 18(3):440-7. PubMed ID: 8829019 [TBL] [Abstract][Full Text] [Related]
53. The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance. Hoban DJ; Jones RN; Harrell LJ; Knudson M; Sewell D Diagn Microbiol Infect Dis; 1993; 17(2):157-61. PubMed ID: 8243037 [TBL] [Abstract][Full Text] [Related]
54. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG; Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257 [TBL] [Abstract][Full Text] [Related]
55. Open randomized controlled parallel study of ofloxacin versus trimethoprim-sulfamethoxazole treatment of lower respiratory tract and urinary infections. De Simone C; Di Fabio S; Moretti S; Tzantzoglou S; Trinchieri V; Gargiulo M Chemotherapy; 1991; 37 Suppl 1():39-48. PubMed ID: 2049964 [TBL] [Abstract][Full Text] [Related]
56. [Comparative antibacterial activity of piperacillin against Pseudomonas aeruginosa, Escherichia coli and Streptococcus faecalis in cultures and human serum]. Just HM; Reiber T; Bassler M; Daschner FD Immun Infekt; 1985 May; 13(3):119-23. PubMed ID: 3924819 [TBL] [Abstract][Full Text] [Related]
57. [Ofloxacin versus pipemidic acid and co-trimoxazole]. Wittenberger R Infection; 1986; 14 Suppl 1():S93-6. PubMed ID: 3514474 [TBL] [Abstract][Full Text] [Related]
58. Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. Block JM; Walstad RA; Bjertnaes A; Hafstad PE; Holte M; Ottemo I; Svarva PL; Rolstad T; Peterson LE Drugs; 1987; 34 Suppl 1():100-6. PubMed ID: 3501750 [TBL] [Abstract][Full Text] [Related]
59. In vitro activity of trimethoprim alone compared with trimethoprim-sulfamethoxazole and other antimicrobials against bacterial species associated with upper respiratory tract infections. Eliopoulos GM; Wennersten CB Diagn Microbiol Infect Dis; 1997 Sep; 29(1):33-8. PubMed ID: 9350413 [TBL] [Abstract][Full Text] [Related]
60. [Evaluation of three automated blood culture systems. Bio Argod, Bact T/Alert, bactec NR-860]. Aubert G; Vautrin AC; Michel VP; Fresard A; Dorche G Pathol Biol (Paris); 1993 Apr; 41(4):434-40. PubMed ID: 8233648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]